BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Oligomenorrhea

Below is an extended Oligomenorrhea patents listing. Click here to return to the Oligomenorrhea main in depth entry.

Patents :

US Patent No.Title
7381409 Antibodies specific for sclerostin and methods of screening and use therefor
5102868 Method for inhibiting follicular maturation
5173404 Immunoassay for follicular regulatory protein
5612312 Method for treating insulin resistance with IGF-I
5637567 Method for modifying, diagnosing, and screening for IGF-I sensitive cell barrier properties
5686408 Method for modifying, diagnosing, and screening for IGF-I sensitive cell barrier properties
5736400 Method for modifying, diagnosing and screening for IGF-I sensitive cell barriers
5767082 Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists
5906979 Compositions and methods for treating metabolic diseases characterized by hyperandrogenism and/or anovulation and/or infertility
4912201 Monoclonal antibodies and antisera to intragonadal regulatory protein
4801577 Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists
4272530 .DELTA..sup.1,3,5(10) -Estratrienes
4291028 Follicular phase estrogen or progestin with physiologic estrogen/progestin luteal phase replacement drug delivery system
4292315 Follicular phase estrogen or progestin with physiologic estrogen/progestin luteal phase replacement drug delivery system
4562178 Use of diethylaminoethyldextran (DEAE-D) as an antihyperinsulinemic drug
4657932 Method of treating prolactin-related disorders
4707475 Agent for lowering serum prolactin levels
4734398 Follicular regulating protein
4764502 Intragonadal regulatory protein
6034075 Method of treating polycystic ovarian syndrome
6180803 19-nor-pregnene derivatives and pharmaceuticals containing such derivatives
7105490 Methods and compositions for treating polycystic ovary syndrome
7153678 Polynucleotides encoding the novel human phosphatase, RET31, and variants thereof
7192583 Methods for modulating bone mineralization
7226902 Ligands for TGF-beta binding proteins and uses thereof
7232667 Keratinocyte growth factor-2 polynucleotides
7291593 Use of fish for treating infertility
7303772 Synergistic phytoceutical compositions
7358074 Human phosphatase RET31, and variants thereof
7105489 Methods and compositions for treating polycystic ovary syndrome
6960337 Methods and compositions for treating benign gynecological disorders
6261800 Luteinizing hormone/choriogonadotropin (LH/CG) receptor
6265393 Prevention of endometriosis signs or symptons
6395511 Nucleic acids encoding a novel family of TGF-.beta. binding proteins from humans
6489445 Polypeptides associated with alterations in bone density
6495736 Compositions and methods for increasing bone mineralization
6635672 Agent for lowering prolactin
6693077 Keratinocyte growth factor-2
6803453 Antibodies associated with alterations in bone density
4242335 Novel 17.alpha.-aryl-steroids
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional